If you could vote on Brexit now which option would you choose?

Pfizer Covid Pill Effective to Stop Hospitalization, New Study Shows

New study data showed Pfizer Inc.’s experimental Covid-19 pill was highly effective at keeping patients out of the hospital, but less adept at erasing milder symptoms often associated with breakthrough infections. Pfizer disclosed findings from two studies in a statement Tuesday. In one, its treatment, Paxlovid, failed to meet the primary goal of reducing self-reported symptoms in 673 adults at standard risk of developing Covid-19 complications. The drug showed a trend toward reducing hospitalizations in the group by 70%, however. In the other study, the treatment remained 89% effective in preventing hospitalizations in high-risk unvaccinated people when used within 3 days of the appearance of symptoms. That confirmed Pfizer’s earlier analysis of results from a smaller number of patients.

Bloomberg - December 14, 2021

View the full story here: https://www.bloomberg.com/news/articles/2021-12-14/pfizer-covid-pill-stops-hospitalizations-not-milder-symptoms